Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CI&T Inc Class A Common Shares (NY: CINT )

7.240 -0.080 (-1.09%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CI&T Inc Class A Common Shares

< Previous 1 2 3 4 5 6 7 Next >
CI&T Reports Strong Fourth Quarter and Full-year 2022 Results
From CI&T Inc.
Via Business Wire
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
CI&T Earnings Preview
Via Benzinga
CI&T Announces Date for the Fourth Quarter and full year of 2022 Earnings Release and Conference Call
From CI&T Inc.
Via Business Wire
CI&T Fuels the Future of Business with Impact Tomorrow Activation at SXSW 2023
From CI&T Inc.
Via Business Wire
CI&T Earns Two Solution Partner Designations in the Microsoft Cloud Partner Program
From CI&T Inc.
Via Business Wire
CI&T and Box1824 present trends study for the next five years
From CI&T Inc.
Via Business Wire
CI&T Releases Third Annual Connected Retail Report – Revealing Intra-Pandemic Consumers Want Consistent Shopping Across All Channels
From CI&T
Via Business Wire
CI&T and Crownpeak Partner to Build Accelerators for Retail Experience Management
From CI&T Inc.
Via Business Wire
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
CI&T Becomes AWS Advanced Tier Services Partner
From CI&T Inc.
Via Business Wire
Cielo Recognizes CI&T as the “Best Supplier” in the Innovation Category
From CI&T Inc.
Via Business Wire
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Via Benzinga
CI&T Reports Solid Third Quarter 2022 Financial and Operational Results
From CI&T Inc.
Via Business Wire
Earnings Scheduled For November 17, 2022
Companies Reporting Before The Bell • Jumia Technologies (NYSE:JMIA) is expected to report quarterly loss at $0.76 per share on revenue of $57.32 million. 
Via Benzinga
CI&T Completes the Acquisition of NTERSOL
From CI&T Inc.
Via Business Wire
CI&T Announces Date for the Third Quarter 2022 Earnings Release and Conference Call
From CI&T Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 53 companies reached new 52-week lows. 
Via Benzinga
CI&T Is One of the Best Companies To Work For in Brazil
From CI&T Inc.
Via Business Wire
CI&T Acquires NTERSOL to Expand Financial Services Expertise in North America
From CI&T Inc.
Via Business Wire
CI&T Wins 2022 Acquia Engage Award for its Work with UNICEF
From CI&T Inc.
Via Business Wire
CI&T Completes the Acquisition of Transpire
From CI&T Inc.
Via Business Wire
Carla Trematore Joins CI&T's Board of Directors
From CI&T Inc.
Via Business Wire
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
9 Information Technology Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. 
Via Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback